DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/15022
Title: Nifedipine-loaded polymeric nanoparticles: Preparation and in vitro characterization
Authors: Ozakar, Emrah
Ceti, Meltem
Ate, Orhan
Hacimuftuoglu, Ahmet
Keywords: FT-IR
in vitro release
nanoparticle
nifedipin
PLGA.
Issue Date: 11-Mar-2019
Publisher: Karachi: Faculty of Pharmacy and Pharmaceutical Sciences, University of Karachi
Citation: Ozakar, E., Cetin, M., Ates, O., & Hacimuftuoglu, A. (2019). Nifedipine-loaded polymeric nanoparticles: Preparation and in vitro characterization. Pakistan Journal of Pharmaceutical Sciences, 32(2).
Abstract: The purpose of the current study was to prepare nifedipine (NF) loaded-PLGA nanoparticles (NPs) using two different methods (nanoprecipitation method (N-2) and emulsion-solvent evaporation method (N-4)) to achieve the sustained release of NF and to reduce its side effects and also to investigate the in vitro characteristics of NPs (surface morphology, particle size and size distribution, encapsulation efficiency and in vitro release characteristics). SEM images of nanoparticles revealed their approximate spherical shape. The mean particle sizes of the prepared nanoparticles ranged from 294.27±7.93 to 424.92±4.96 nm with almost neutral zeta potential values (close to 0 mV). The percent encapsulation efficiency values of N-2 and N-4 formulations 13.03±1.82% and 18.96±1.95% (p=0.05), respectively. The extents of cumulative drug release from N-2 and N-4 in PB pH 7.4 medium were up to about 100 % in 38 days and 22 days, respectively (when comparing two formulations, p<0.05). PLGA nanoparticles are useful systems for the sustained release of NF, and hence for reducing its side-effects and increasing patient compliance.
URI: http://142.54.178.187:9060/xmlui/handle/123456789/15022
ISSN: 1011-601X
Appears in Collections:Issue 2

Files in This Item:
File Description SizeFormat 
Paper-11.htm132 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.